News
A
134.98
+0.61%
0.82
Agilent: Making A Move To Ignite Some Growth
Seeking Alpha · 1d ago
Lithium Miners News For The Month Of July 2024
Seeking Alpha · 1d ago
Madison Sustainable Equity Fund Q2 2024 Investment Strategy Letter
Seeking Alpha · 1d ago
Madison Investors Fund Q2 2024 Investment Strategy Letter
The Madison Investors Fund (Class Y) decreased 1.03% in the second quarter of 2024, compared to the 4.28% increase in the S&P 500 index. The top five individual contributors to performance relative to the benchmark were Alphabet, Analog Devices, Arch Capital, and TJX Companies.
Seeking Alpha · 1d ago
Agilent’s Strategic Acquisition of BIOVECTRA: A Path to Growth and Improved Margins
TipRanks · 2d ago
Agilent (A) Receives a Buy from TD Cowen
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Lifestance Health Group (LFST) and Agilent (A)
TipRanks · 3d ago
Barclays Keeps Their Sell Rating on Agilent (A)
TipRanks · 3d ago
(A) - Analyzing Agilent Technologies's Short Interest
Agilent Technologies's short percent of float has risen 45.05% since its last report. The company has 4.15 million shares sold short, which is 1.61% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 4d ago
Agilent (A) Boosts DCG Segment With New ProteoAnalyzer System
NASDAQ · 4d ago
*Agilent to Acquire North Amer CDMO BIOVECTRA for $925M
Dow Jones · 4d ago
*Agilent To Acquire North American CDMO BIOVECTRA >A
Dow Jones · 4d ago
Weekly Report: what happened at A last week (0715-0719)?
Weekly Report · 4d ago
Agilent to Acquire North American CDMO BIOVECTRA
Agilent Technologies Inc. Today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization for $925 million. Based in Canada, BIovECTRA produces biologics, highly potent active pharmaceutical ingredients, and other molecules. The acquisition builds on Agilent’s expertise in CRISPR and gene-editing technology.
Barchart · 4d ago
Agilent Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit
Agilent Technologies Inc. Announced the release of its new ProteoAnalyzer system at the Singapore Cell and Gene Therapy Pan Asia Summit. The new protein analysis platform combines rapid, high-resolution analysis with minimal sample consumption. Agilent also announced an update to its Flow Cytometer product line at SCGT.
PR Newswire · 5d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of July 21
Seeking Alpha · 6d ago
Press Release: Agilent to Announce Third-Quarter Fiscal Year 2024 Financial Results Aug. 21
Dow Jones · 07/16 20:04
NIH outlays rise by 5% in June, says Baird
Seeking Alpha · 07/16 19:02
Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet
Agilent Technologies, Inc. (NYSE:A) has US$2.56b of debt. The company uses debt to fund its operations. Agilent has a low net debt to EBITDA ratio of 0.55. Its debt load is not too heavy, and its EBIT is enough to cover its interest costs. The balance sheet is a good place to look at to see if a company is at risk of debt overload. But should shareholders be worried about its use of debt? We look at AgilENT Technologies's free cash flow and debt levels.
Simply Wall St · 07/15 10:36
Weekly Report: what happened at A last week (0708-0712)?
Weekly Report · 07/15 09:02
More
Webull provides a variety of real-time A stock news. You can receive the latest news about Agilent Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About A
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers services portfolio, which includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the laboratory operations.